ANLAdlai Nortye Ltd.
What is the market doing?
In an uptrend. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
In an uptrend, above its rising 50- and 200-day averages. Price is +46% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ANL is trading
Adlai Nortye Ltd. is +796% over the past year while the S&P 500 is +18%: 778 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +46%
vs 200-day average · a clear uptrend
- RSI (14)
- 47
RSI (14) · neutral
- Below its 52-week high
- 6.6%
Below its 52-week high
Details›
- Last close2026-10-08
- $15.50
- 1 monthS&P 500 +1.6%
- +5.5%
- 1 yearS&P 500 +18%
- +796%
- vs 50-day average$14.48
- +7.1%
- 52-week high
- $16.60
- 52-week low
- $0.88
- Annualised volatility
- 124%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$132
| Year | Return |
|---|---|
| 2026 (year to date) | +992% |
| 2025 | −47% |
| 2024 | −70% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 3 | 2 of 3 | +210% |
| Feb | 3 | 1 of 3 | −14% |
| Mar | 3 | 1 of 3 | +0.39% |
| Apr | 3 | 2 of 3 | +51% |
| May | 3 | 0 of 3 | −22% |
| Jun | 3 | 0 of 3 | −26% |
| Jul | 3 | 2 of 3 | +5.7% |
| Aug | 3 | 2 of 3 | +2.4% |
| Sep | 3 | 2 of 3 | −3.6% |
| Oct | 4 | 1 of 4 | −17% |
| Nov | 3 | 3 of 3 | +20% |
| Dec | 3 | 1 of 3 | −2.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Biotechnology
The closest names by size in the same industry